MARKET FORECASTS FOR SHORT-TERM ILLNESSES 142
Rotavirus 142
Ear Infections 142
Upper Respiratory Infections 142
MARKET FORECASTS FOR CHRONIC ILLNESSES 142
Allergies 143
Attention Deficit Disorders 143
Asthma 143
Autism Spectrum Disorders 144
Diabetes 144
Obesity 144
OVERVIEW OF THE PEDIATRIC HEALTHCARE INDUSTRY 145
TABLE 50 PROJECTED PEDIATRIC PREVENTATIVE CARE COSTS FROM BIRTH THROUGH AGE 18 IN THE U.S., THROUGH 2013 ($ MILLIONS) 145
PRENATAL CARE/IMPLICATIONS 145
International Prenatal Care/Implications 146
Low Birth Weight 146
NEWBORN CARE 147
Care in the U.S. 147
International Newborn Care 147
Malnutrition 148
CHILDREN AGE 1 TO 6 148
CHILDREN AGE 7 TO 12 149
ADOLESCENT CHILDREN AGE 13 TO 18 149
ADOLESCENT REPRODUCTIVE HEALTH 150
Sexually Transmitted Diseases 150
Human Papillomavirus (HPV) 150
VACCINES/IMMUNIZATIONS 151
TABLE 51 IMMUNIZATION SCHEDULE FOR CHILDREN FROM BIRTH TO 6 MONTHS 151
TABLE 52 IMMUNIZATION SCHEDULE FOR CHILDREN FROM 12 MONTHS TO 4 TO 6 YEARS 152
TABLE 53 IMMUNIZATION SCHEDULE FOR CHILDREN AND ADOLESCENTS FROM 7 TO 18 152
TABLE 53 (CONTINUED) 153
Vaccine Efficacy and Controversy 153
IMPLICATIONS FOR FUTURE DEVELOPMENTS IN THE U.S. 153
SHORT-TERM ILLNESSES IN THE PEDIATRIC POPULATION 154
TABLE 54 GLOBAL COSTS OF THREE PRIMARY SHORT-TERM ILLNESSES IN PEDIATRIC POPULATION, THROUGH 2013 ($ MILLIONS) 155
FIGURE 23 GLOBAL COST OF PEDIATRIC SHORT-TER
'/>"/>
| SOURCE Reportlinker Copyright©2009 PR Newswire. All rights reserved |